US Patent 8440665 Apoptosis signal-regulating kinase inhibitors
Patent 8440665 was granted and assigned to Gilead Sciences on May, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 23 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 18 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 30 Nov, 2023
Golden AI
Edits made to:
Article (+73 characters)
Article
Patent abstract
The present invention relates to compounds of Formula (I):
Edits on 21 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Britton Corkey0
Gregory Notte0
Jeff Zablocki0
Edits on 14 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08440665 Apoptosis signal-regulating kinase inhibitors US Patent 8440665 Apoptosis signal-regulating kinase inhibitors
Infobox
Patent Number
084406650
Patent Number
84406650
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
084406650
Date of Patent
May 14, 2013
0Patent Application Number
131744590
Date Filed
June 30, 2011
0Patent Primary Examiner
Edits on 16 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08440665 Apoptosis signal-regulating kinase inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08440665
Date of patent
May 14, 2013
Patent application number
13174459
Date Filed
June 30, 2011
Patent primary examiner
Find more entities like US Patent 8440665 Apoptosis signal-regulating kinase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.